Ansh Labs

Immunoassay Kits and Reagentsanshlabs.com

Company typePrivate
Founded1990
HeadquartersWebster, United States
Headcount11–50
GTM typeB2B
OfferingHardware or Manufacturing

Ansh Labs firmographics

Firmographics

Name: Ansh Labs
Legal name: Ansh Labs
Website: https://anshlabs.com
Company type: Private
Founded year: 1990
Operating status: Operating
Headcount range: 11–50 employees
Ownership category
akta.pro rank

Ansh Labs industry classification

Industry

Product category: Immunoassay Kits and Reagents
NAICS: In-Vitro Diagnostic Substance Manufacturing (325413)
SIC: In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro primary industry: Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)
akta.pro secondary industries: Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB), Immunoassay Diagnostics (ELISA, chemiluminescence, serology) (HLAAALAB)

Keywords

Immunoassay development
ELISA kits
Monoclonal antibodies
Diagnostic reagents
Biomarker assays

Where Ansh Labs is headquartered

Location

Headquarters

HQ city: Webster
HQ country: United States
HQ region: North America

Offices1 record

Markets served

Ansh Labs business model

Business model

GTM type: B2B
Offering type: Hardware or Manufacturing
Cost components: Personnel, Technology/R&D, Operations, Supply Chain, Marketing/Sales

Revenue model

Immunoassay Product Sales: Sale of ELISA kits, CLIA kits, and immunoassay reagents for research use only (RUO), in vitro diagnostic (IVD), and CE marked applications. Products include highly specific assays with 24-month shelf lives.
Antibody and Antigen Sales: Sale of monoclonal antibodies and recombinant antigens for research applications. Includes purified antibodies, hybridoma products, and recombinant proteins.
Custom Immunoassay Development Services: Custom assay development services including ELISA kits, custom biochemical reagents (antibodies, protein and small molecule antigens, specialized conjugates), assay optimization and validation for clinical diagnostics.

Pricing tiers

Model	Billing	Price
One time/ perpetual license	Pay-as-you-go	ELISA Kits - Research Use Only (RUO)
One time/ perpetual license	Pay-as-you-go	Monoclonal Antibodies
One time/ perpetual license	Pay-as-you-go	MenoCheck picoAMH ELISA (FDA Cleared)
One time/ perpetual license	Pay-as-you-go	C-Peptide of Insulin ELISA

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Ansh Labs product offering

Product offering

Core offering

Ansh Labs develops and manufactures immunodiagnostic assays and reagents, including ELISA and CLIA kits, monoclonal antibodies, recombinant antigens, and custom biochemical reagents for translational research and clinical diagnostics. The company also offers custom immunoassay development services and provides FDA-cleared, CE-marked, and Research Use Only (RUO) versions of its products to research and clinical laboratories, pharmaceutical/biotech firms, and veterinary diagnostic customers worldwide.

Product overview

Ansh Labs is an immunoassay development company specializing in novel clinical diagnostic markers with applications in reproductive medicine, neurodegenerative disorders, oncology, and metabolism. The product portfolio consists of immunoassay kits (ELISA and CLIA formats), monoclonal antibodies, antigens, and biochemical reagents. Key products include the FDA-cleared MenoCheck picoAMH ELISA for menopausal status determination, various reproductive hormone assays (Inhibin, Activin, FSH, LH, AMH), glucagon regulation assays (GLP-1, GLP-2, Glucagon, Glicentin, Oxyntomodulin), growth factor assays (IGF, IGFBP, GDF, PAPP-A), and species-specific assays for veterinary research (bovine, equine, canine, porcine, ovine). The company offers custom immunoassay development services for unique assay needs.

Differentiator

Problem solved

Functional benefit

Brands

MenoCheck: FDA cleared in vitro diagnostic test for determining menopausal status in women between 42 and 62 years of age.

Products and services

MenoCheck picoAMH ELISA

Quantifiable outcome

24-month shelf life for immunoassay products
+1 more outcomes

Companies that use Ansh Labs

Customer profile

Segments3 records

Ideal customer profiles3 records

Ansh Labs technology and API

Technology

Technology focussed No

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Ansh Labs partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Ansh Labs competitors and assessment

Company assessment

Broad incumbents

Roche Diagnostics: Roche Diagnostics is a global diagnostics leader offering FDA-cleared immunoassays for reproductive hormones (e.g., AMH/Elecsys) and metabolic markers on automated platforms; Ansh Labs competes with Roche's specialty biomarker menu, particularly where labs prefer RUO/ELISA flexibility over high-throughput automated analyzers.
Bio-Techne (R&D Systems): Bio-Techne, through its R&D Systems brand, is a much larger life-science tools incumbent offering thousands of ELISA kits, antibodies, and reagents across reproductive, metabolic, and immunology biomarkers; Ansh Labs competes in overlapping analyte categories but from a much smaller and more specialized base.
Abcam: Abcam (now part of Danaher) is a broad incumbent supplying antibodies and ELISA kits across reproductive hormones, growth factors, and metabolic biomarkers; its catalog and distribution scale overlap with Ansh Labs' specialty reproductive and TGF-beta superfamily offerings.
Beckman Coulter: Beckman Coulter provides automated chemiluminescent immunoassays for fertility hormones and metabolic analytes, competing with Ansh Labs' specialty CLIA kits (e.g., FSH CLIA) but at much larger scale and via installed instrument bases.

Direct peers

Calbiotech / Eagle Biosciences: Eagle Biosciences (distributing Calbiotech assays) is a specialty immunoassay distributor and developer offering ELISA kits for reproductive hormones, growth factors, and metabolic biomarkers, directly competing with Ansh Labs for translational and clinical lab accounts.
DRG International: DRG International is named alongside Ansh Labs as a co-holder of over 50% market share in the Fertility ELISA Test Kit Market, selling immunoassays (ELISA and CLIA) for reproductive endocrinology and other specialty biomarkers with a comparable global distributor network.
Sure Bio-Tech: Sure Bio-Tech is the fourth named participant in the Fertility ELISA Test Kit Market alongside Ansh Labs, DRG International, and Monobind, offering immunoassays for reproductive hormones and related biomarkers in a directly overlapping product category.
ALPCO Diagnostics: ALPCO Diagnostics is a US-based specialty immunoassay developer focused on ELISA kits for metabolic, reproductive, and gastrointestinal biomarkers, closely overlapping Ansh Labs' catalog (e.g., GLP-1, glucagon, AMH, IGF-1) and serving the same translational research and clinical lab customer base.
Kamiya Biomedical: Kamiya Biomedical is a US-based specialty immunoassay manufacturer offering ELISA kits for reproductive, metabolic, and oncology biomarkers with RUO and clinical positioning closely paralleling Ansh Labs' product portfolio and customer segments.
Monobind: Monobind is identified in industry market-share data as one of four players (with Ansh Labs) controlling the majority of the Fertility ELISA Test Kit Market, and manufactures ELISA and CLIA kits for hormones, fertility, and metabolic biomarkers with similar RUO/IVD positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Ansh Labs compliance and trust

Trust signal

Compliance3 records

Ansh Labs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ansh Labs leadership team

Management profile

Number of profiles

Profiles3 records

Ansh Labs funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ansh Labs M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ansh Labs

What does Ansh Labs do?

Is Ansh Labs a public or private company?

Ansh Labs is a private company. It is classified as corporate owned and is currently operating.

When was Ansh Labs founded?

Ansh Labs was founded in 1990. It employs 11 to 50 people.

Where is Ansh Labs based?

Ansh Labs is headquartered in Webster, United States, in the North America region.

How does Ansh Labs make money?

Three revenue lines are on record. Immunoassay Product Sales are the primary driver. The others are antibody and Antigen Sales and custom Immunoassay Development Services.

Who are Ansh Labs's main competitors?

Broad incumbents on record are Roche Diagnostics, Bio-Techne (R&D Systems), Abcam and Beckman Coulter. Direct peers are Calbiotech / Eagle Biosciences, DRG International, Sure Bio-Tech, ALPCO Diagnostics, Kamiya Biomedical and Monobind.

Does Ansh Labs have an API?

No public API is recorded for Ansh Labs.

What industry is Ansh Labs in?

Ansh Labs's product category is Immunoassay Kits and Reagents. Its primary akta.pro industry code is HLAAAMAL, Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls), with a secondary code of HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes). Its NAICS code is 325413 and its SIC code is 2835.